Hsu, S.-J.; Huang, H.-C.; Chuang, C.-L.; Chang, C.-C.; Hou, M.-C.; Lee, F.-Y.; Lee, S.-D.
Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats. Pharmaceutics 2020, 12, 320.
https://doi.org/10.3390/pharmaceutics12040320
AMA Style
Hsu S-J, Huang H-C, Chuang C-L, Chang C-C, Hou M-C, Lee F-Y, Lee S-D.
Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats. Pharmaceutics. 2020; 12(4):320.
https://doi.org/10.3390/pharmaceutics12040320
Chicago/Turabian Style
Hsu, Shao-Jung, Hui-Chun Huang, Chiao-Lin Chuang, Ching-Chih Chang, Ming-Chih Hou, Fa-Yauh Lee, and Shou-Dong Lee.
2020. "Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats" Pharmaceutics 12, no. 4: 320.
https://doi.org/10.3390/pharmaceutics12040320
APA Style
Hsu, S.-J., Huang, H.-C., Chuang, C.-L., Chang, C.-C., Hou, M.-C., Lee, F.-Y., & Lee, S.-D.
(2020). Dual Angiotensin Receptor and Neprilysin Inhibitor Ameliorates Portal Hypertension in Portal Hypertensive Rats. Pharmaceutics, 12(4), 320.
https://doi.org/10.3390/pharmaceutics12040320